Gene Expression Biomarkers of Response to Citalopram Treatment in Major Depressive Disorder

Translational Psychiatry - United Kingdom
doi 10.1038/tp.2011.12
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Association of Mu-Opioid Receptor Variants and Response to Citalopram Treatment in Major Depressive Disorder

American Journal of Psychiatry
PsychiatryMental Health
2010English

Omega-3 Fatty Acid Augmentation of Citalopram Treatment for Patients With Major Depressive Disorder

Journal of Clinical Psychopharmacology
PsychiatryMental HealthPharmacology
2012English

Gene Expression Profiling in Postmortem Prefrontal Cortex of Major Depressive Disorder

Journal of Neuroscience
Neuroscience
2007English

Possible Association of CUX1 Gene Polymorphisms With Antidepressant Response in Major Depressive Disorder

Pharmacogenomics Journal
Molecular MedicineGeneticsPharmacology
2012English

Duloxetine in the Treatment of Major Depressive Disorder

Journal of Clinical Psychiatry
MedicinePsychiatryMental Health
2002English

Maternal Depressive Symptoms in Pediatric Major Depressive Disorder: Relationship to Acute Treatment Outcome

Journal of the American Academy of Child and Adolescent Psychiatry
PsychiatryDevelopmentalMental HealthEducational Psychology
2008English

The Psychomotor Retardation, a Marker of Response to rTMS Treatment in Patients With Major Depressive Disorder?

Neuropsychiatry
PsychiatryMental HealthNeurology
2017English

Resting-State Connectivity Predictors of Response to Psychotherapy in Major Depressive Disorder

Neuropsychopharmacology
PsychiatryMental HealthPharmacology
2015English

Metabolic and Microbiota Measures as Peripheral Biomarkers in Major Depressive Disorder

Frontiers in Psychiatry
PsychiatryMental Health
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy